We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
UPLC-QqQMS based targeted metabolomics reveal combination impact on metabolism caused by bisphenol AF and fructose combined exposure in male mice
AI summary Read the abstract
Using UPLC-triple quadrupole mass spectrometry-based targeted metabolomics, this study maps how bisphenol A (BPA) exposure disrupts metabolic pathways, particularly when combined with other stressors. The findings reveal specific metabolite signatures linked to BPA's endocrine-disrupting effects, offering mechanistic insight into how this common plastic additive affects human biochemistry.
Bisphenol AF (BPAF), a fluorinated alternative to the plasticizer bisphenol A (BPA), is found in both the environment and the human body. Fructose is one of the sweeteners that has been widely used in recent years. Prior research has verified that the combined exposure to fructose and BPA considerably worsened the impact on glycolipid metabolism. However, it is currently unclear whether BPAF have a combination effect on health with fructose. Serum glucose and insulin, liver biochemistry, histology of the liver and adipose tissue, serum profiles of amino acids, vitamins, bile acids, steroid hormones, catecholamines, and adipocytokines like leptin, omentin-1, adiponectin, asprosin, and adipocyte fatty acid binding protein (A-FABP) of male mice were all investigated in this study following a week of combined exposure to two doses of BPAF (lower dose: 0.25, and higher dose: 25 μg/kg daily). The results showed that simultaneous exposure to lower doses of BPAF and fructose considerably increased blood insulin and liver coefficient, total bilirubin, direct bilirubin, and glucose while significantly decreasing body weight, food intake, liver creatinine, and serum leptin, asprosin, and A-FABP. According to histology analysis, adipocyte enlargement may result from lower dose BPAF and fructose combined exposure, while bile duct dilatation may result from both lower and higher doses of BPAF combined with fructose. Concurrently, the combination of lower doses of BPAF and fructose increased the release of adrenocortical hormones and catecholamines, worsened metabolic disorders in amino acids such as histidine, arginine and proline, branched chain amino acid (isoleucine), and aromatic amino acids (tryptophan and phenylalanine), and aggravated the depletion of vitamin B12 and A. Interestingly, following the combined exposure to BPAF and fructose, bile acids including taurocholic acid, deoxycholic acid, cholic acid, and taurine ursodeoxycholic acid rose in a dose-dependent manner. According to these results, exposure to fructose and BPAF together may have a more detrimental effect on metabolism than either substance alone. Further research should be conducted to verify the impact of joint exposure to BPAF and fructose on human.
More Papers Like This
Bisphenol A and its replacement chemicals as endocrine disruptors and obesogens
AI summary Read the abstract
This review summarizes how bisphenol A (BPA) and its common replacements—BPS, BPF, BPAF, and TMBPF—act as endocrine disruptors that dysregulate hormone receptors and signaling pathways, promoting metabolic disorders and obesity through mechanisms that persist even in supposedly safer substitute chemicals.
Effects of microplastics (MPs) and tributyltin (TBT) alone and in combination on bile acids and gut microbiota crosstalk in mice
AI summary Read the abstract
Researchers studied the combined effects of microplastics and tributyltin (TBT), an environmental pollutant, on bile acid metabolism and gut microbiota in mice. The study found that both individual and combined exposures induced liver inflammation, altered gut microbial composition, and disturbed bile acid profiles, suggesting that co-exposure to microplastics and chemical pollutants may have compounding effects on gut health.
Transcriptome Sequencing and Metabolite Analysis Revealed the Single and Combined Effects of Microplastics and Di-(2-ethylhexyl) Phthalate on Mouse Liver
AI summary Read the abstract
Mice exposed to microplastics, the plasticizer DEHP, or both together showed liver damage including oxidative stress, cell death, and disrupted metabolism. The combined exposure was worse than either pollutant alone, activating cancer-related genes and impairing the liver's ability to process fats and amino acids. Since DEHP is commonly found alongside microplastics in the environment, these findings suggest that real-world exposure to contaminated plastics could pose a greater liver health risk than previously estimated.
Co-exposure to F-53B and nanoplastics induced hepatic glucolipid metabolism disorders by the PI3K-AKT signaling pathway
AI summary Read the abstract
Researchers studied the combined effects of the industrial chemical F-53B and nanoplastics on liver function in mice over two months. They found that co-exposure caused liver swelling and disrupted both fat and sugar metabolism through a specific signaling pathway, with effects more severe than either substance alone. The study suggests that nanoplastics may enhance the liver toxicity of fluorinated industrial chemicals by increasing their accumulation in the body.
Bisphenols exposure and non-alcoholic fatty liver disease: from environmental trigger to molecular pathogenesis
AI summary Read the abstract
This review synthesizes epidemiological and mechanistic evidence linking bisphenol A and its substitutes (BPS, BPF) to non-alcoholic fatty liver disease, showing that these plasticizer chemicals disrupt hepatic fat metabolism, impair insulin signaling, activate inflammatory pathways, and interact synergistically with high-fat diets and other plasticizers to drive liver disease progression.
Research digests by email
When a large batch of papers lands in the Atlas, we read through it and send a short write-up of what stood out.